Metoprolol succinate extended release/hydrochlorothiazide combination tablets

References

• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diureticJAMA200228829819712479763
   PubMed Web of Science ®Google Scholar
• BakrisGLFonsecaVKatholiREMetabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertensionJAMA200429222273615536109
   PubMed Web of Science ®Google Scholar
• BeermannBGroschinsky-GrindMRosenAAbsorption, metabolism, and excretion of hydrochlorothiazideClin Pharmacol and Thera1976195317
   PubMed Web of Science ®Google Scholar
• DahlofBLindholmLHHanssonLMorbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension)Lancet1991338128151682683
   PubMed Web of Science ®Google Scholar
• DarmansjahIWongESetiawatiAPharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenololJ Clin Pharmacol199030S39S452312778
   PubMed Web of Science ®Google Scholar
• DornhorstAPowellSHPenskyJAggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretionLancet1985112362857210
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertension200321101153
   PubMed Web of Science ®Google Scholar
• FalknerBFrancosGKushnerHMetoprolol succinate, a selective ß-adrenergic blocker, has no effect on insulin sensitivityJ Clin Hypertension2006833643
   Google Scholar
• GeislerLSHypertension therapy in the elderlyMedWelt19813291014
   PubMed Web of Science ®Google Scholar
• GoodfellowRWestbergBThe treatment of high blood pressure in the elderly: a multi-center evaluation of a fixed combination of metoprolol and hydrochlorothiazide (Co-Betaloc) in general practiceCurr Med Res Opin19817536427307545
   PubMed Web of Science ®Google Scholar
• GuQPaulose-RamRDillonCBurtVAntihypertensive medication use among US adults with hypertensionCirculation20061132132116391156
   PubMed Web of Science ®Google Scholar
• HajjarIKotchenTTrends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000JAMA200329019920612851274
   PubMed Web of Science ®Google Scholar
• HanssonLLindholmLHEkbomTRandomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish trial in old patients with hypertension-2 studyLancet19993541751610577635
   PubMed Web of Science ®Google Scholar
• HawkinsDWDieckmannMRHornerRDDiuretics and hypertension in black adultsArch Intern Med198814880353281620
   PubMedGoogle Scholar
• HildemannSKFischerHPittrowDMetoprolol succinate SR plus hydrochlorothiazide (Beloc-Zok® Comp) in patients with essential hypertension in general practice. A prospective, observational trial in 14,964 patientsClin Drug Invest20022271929
   Web of Science ®Google Scholar
• HollandOBFairchildCRenin classification for diuretic and beta-blocker treatment of black and hypertensive patientsJ Chron Dis198235179826120945
   PubMedGoogle Scholar
• HydroDiuril^® (hydrochlorothiazide) professional information brochure1998Merck & Co., Inc
   Google Scholar
• JNC 7 reportChobanianAVBakrisGLBlackHRThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressureJAMA200328925607112748199
   PubMed Web of Science ®Google Scholar
• JordoLJohnssonGLundborgPBioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazideBr J Clin Pharmacol197975637465277
   PubMed Web of Science ®Google Scholar
• JuliusSNesbittSDEaganBMFeasibility of treating prehypertension with an angiotensin-receptor blockerN Engl J Med200635416859716537662
   PubMed Web of Science ®Google Scholar
• LaPalioLSchorkAGlasserSSafety and efficacy of metoprolol in the treatment of hypertension in the elderlyJ Am Geriatr Soc19924035481556363
   PubMed Web of Science ®Google Scholar
• MouradJ-JWaeberBZannadFon behalf of the investigators of the STRATHE trialComparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approachJournal of Hypertension20042223798615614033
   PubMed Web of Science ®Google Scholar
• OfiliEDispelling the myth of “aggressive” antihypertensive therapyJ Clin Hypertens20068Suppl 1411
   Google Scholar
• PapademetriouVHainerJWSuggJATTACH Study GroupFactorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combinationAm J Hypertens20061912172517161766
   PubMed Web of Science ®Google Scholar
• PapademetriouVReifMHenryDCombination therapy with candesartan cilexetil and hydrochlorothiazide in patients with systemic hypertensionJ Clin Hypertens200023728
   Google Scholar
• PloskerGLClissoldSPControlled release metoprolol formulations: a review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart diseaseDrugs1992433824141374320
   PubMed Web of Science ®Google Scholar
• PsatyBMLumleyTFurbergCHealth outcomes associated with various antihypertensive therapies used as first-line agentsJAMA200328925344412759325
   PubMed Web of Science ®Google Scholar
• SamuelssonOHednerTBerglundGDiabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the primary prevention trial Goteborg, SwedenJ Hum Hypertens19948257637912734
   PubMed Web of Science ®Google Scholar
• SandbergARagnarssonGJonssonUEDesign of a new multiple-unit controlled-release formulation of metoprolol – metoprolol CREur J Clin Pharmacol198833S3S73371391
   PubMed Web of Science ®Google Scholar
• SandbergAAbrahamssonBRegârdhC-GPharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review articleJ Clin Pharmacol199030S2S162179280
   PubMed Web of Science ®Google Scholar
• The Association of Black Cardiologists (ABC) Candesartan Study GroupEvaluation of candesartan cilexetil in black patients with systemic hypertension: The ABC TrialHeart Dis20002392911728289
   PubMedGoogle Scholar
• TOPROL-XL^® (metoprolol succinate) Extended Release Tablets professional information brochure2005AstraZeneca LP
   Google Scholar
• TurnbullFNealBAlgertCEffects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsLancet200336215273514615107
   PubMed Web of Science ®Google Scholar
• WikstrandJWestergrenGBerglundGAntihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 yearsJAMA19862551304103511308
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization, International Society of Hypertension Writing GroupWorld Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJ Hypertens20032119839214597836
   PubMed Web of Science ®Google Scholar